期刊文献+

妊娠期哮喘药物治疗及安全性的新认识 被引量:2

原文传递
导出
摘要 目的哮喘是一种严重危害人类健康的疾病,妊娠期哮喘具有其特殊性,如何在保证妇儿安全的基础上合理有效地使用控制哮喘药物是临床上关注的热点。方法根据妊娠期哮喘的危害和这一时期用药特点和可能引起的不良反应,对各类药物的安全性进行评价,并就药物相互作用进行了简单分析。结果与结论通过妊娠期哮喘教育使患者正确使用哮喘药物。
作者 张羽钦 朱珠
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第4期316-318,共3页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献25

  • 1MURK W, RISNES K R, BRACKEN M B. Prenatal or early-life exposure to antibiotics and risk of childhood asthma : a systematic review[Jl. Pediatrics, 2011, 127(6): 1125-1138.
  • 2POWELL H, MCCAFFERY K, MURPHY V E, et al. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma [ J ]. J Asthma, 2011 , 48 ( 10 ) : 1032-1040.
  • 3POWRIE R O, LARSON L, MILLER M. Managing asthma in expectant mothers[ J]. Treat Respir Med, 2006, 5 (1) : 1-10.
  • 4ARTAMA M, GISSLER M. Nationwide register-based surveillance system on drugs and pregnancy in Finland [ J ]. Pharmacoepidemiol Drug Saf, 2011, 20(7) : 729-738.
  • 5TAILLE C. Asthma and pregnancy[J]. Rev Prat, 2011, 61 ( 3 ) : 368-370.
  • 6SERVIC O. de Pneumologia. Lung disease and pregnancy[J ]. Acta Med Port, 2007, 20(4) : 359-368.
  • 7NWARU B - ERKKOLA M, AHONEN S, et al. Intake of antioxidants during pregnancy and the risk of allergies and asthma in the offspring[J]. Eur J Clin Nutr, 2011, 65(8) :937-943.
  • 8MURPHY V E, GIBSON P G. Asthma in pregnancy[ J]. Clin Chest Med, 2011, 32(1) :93-110.
  • 9LIN S, HERDT-LOSAVIO M, GENSBURG L, et al. Maternal asthma, asthma medication use, and the risk of congenital heart defects [ J ]. Birth Defects Res A Clin Mol Teratol, 2009, 85 ( 2 ) : 161-168.
  • 10FREITAS MDA G, DUARTE A C. Asthma and pregnancy -- efficacy and safety of medication during pregnancy [ J]. Rev Port Pneumol, 2004, 10(5) : 405-419.

同被引文献26

  • 1Renée M Marchioni,Gary R Lichtenstein.Tumor necrosis factor-α inhibitor therapy and fetal risk:A systematic literature review[J].World Journal of Gastroenterology,2013,19(17):2591-2602. 被引量:11
  • 2羊梅兰,陈康德.妊娠期抗菌药物的合理应用[J].浙江中医药大学学报,2006,30(5):485-486. 被引量:6
  • 3Powrie RO,Larson L,Miller M.Managing asthmain expectant mothers[J].Treat Respir Med,2006,5(1):1.
  • 4Zairina E,Stewart K,Abramson MJ,et al.The effectiveness of non-pharmacological healthcare interventions for asthma management during pregnancy[J].BMC Pulm Med,2014(14):46.
  • 5National Heart,Lung and Blood Institute,National Asthma Education and Prevention Program Asthma and Pregnancy Working Group.NAEPP expert panel report:Managing asthma during pregnancy,recommendations for pharmacologic treatment2004update[J].J Allergy Clin Immunol,2005,115(3):477.
  • 6史亦丽,张继春.600种药物妊娠期安全等级检索表[M].1版.北京:中国医药科技出版社,2011:1.
  • 7Eltonsy S,Kettani FZ,Blais L.Beta2-agonists use during pregnancy and perinatal outcomes:a systematic review[J].Respir Med,2014,108(1):9.
  • 8Berger WE,Noonan MJ.Treatment of persistent asthma with Symbicort(budesonide/formoterol inhalation aerosol):an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler[J].J Asthma,2010,47(4):447.
  • 9Edin HM,Andersen LB,Schoaf L,et al.Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.Annals of allergy[J].Ann Allergy Asthma Immunol,2009,102(4):323.
  • 10Addis A,Sharabi S,Bonati M.Risk classification systems for drug use during pregnancy:are they a reliable source of information[J].Drug Saf,2000,23(3):245.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部